# (CIRRUS-2023-1) CLINICAL CLIN Assessment of PathFinder 1.0 on the CIRRUS 6000 and the CIRRUS 5000

> **NCT07680244** · NA · RECRUITING · sponsor: **Carl Zeiss Meditec-Dublin CoCe** · enrollment: 400 (estimated)

## Conditions studied

- Epiretinal Membrane
- Dry Age Related Macular Degeneration
- Macular Abnormalities
- Retina Disease
- Vitreoretinal Abnormality
- Intraretinal Hyporeflective Space
- Subretinal Hyporeflective Space
- IS/OS (Ellipsoid Zone) Disruption
- Retinal Pigment Epithelium (RPE) Elevation
- Retinal Pigment Epithelium (RPE) Atrophy

## Interventions

- **DEVICE:** PathFinder 1.0 on CIRRUS HD-OCT

## Key facts

- **NCT ID:** NCT07680244
- **Lead sponsor:** Carl Zeiss Meditec-Dublin CoCe
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-05-23
- **Primary completion:** 2026-08
- **Final completion:** 2026-08
- **Target enrollment:** 400 (ESTIMATED)
- **Last updated:** 2026-08-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07680244

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07680244, "(CIRRUS-2023-1) CLINICAL CLIN Assessment of PathFinder 1.0 on the CIRRUS 6000 and the CIRRUS 5000". Retrieved via MORVS 2026-10-21 from https://api.morvs.ai/clinical/NCT07680244. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*